Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $137.4500 (0.47%) ($137.4500 - $137.4500) on Mon. Jun. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.43% (three month average) | RSI | 88 | Latest Price | $137.4500(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND advances 5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.215% in a week (0% probabilities). VIXM(-27%) UUP(-17%) VXX(-16%) IGOV(-6%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.215% (StdDev 2.43%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $133.36(3.07%) | 10 Day Moving Average | $130.18(5.58%) | 20 Day Moving Average | $124.39(10.5%) | To recent high | -11.5% | To recent low | 21.7% | Market Cap | $2.209b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |